Research map: Quantifying target antigen-dependent CAR T-cell performance against AML
Back to the article
Papers in this map
Acute Myeloid Leukemia
· Hartmut Döhner · 2015 · 3453 citations · Cited by this paper
Limb-bud and heart (LBH) promotes expansion and survival of esophageal adenocarcinoma cells
· 2026 · Related
The Functional Response of Predators to Prey Density and its Role in Mimicry and Population Regulation
· Crawford S. Holling · 1965 · 2734 citations · Cited by this paper
Novel role of the class II α-isoform of phosphatidylinositol 3-kinase in hepatocellular carcinoma: suppressing metastasis by targeting Wnt/β-catenin signaling via inhibiting phosphorylation of LRP6
· 2026 · Related
Graphical Representation and Stability Conditions of Predator-Prey Interactions
· Michael L. Rosenzweig · 1963 · 2085 citations · Cited by this paper
M196R-TNFR2 and membrane TNFα down-regulate soluble TNFα-induced pro-metastatic functions in triple-negative breast cancer cells
· 2026 · Related
Fluctuations in the Abundance of a Species considered Mathematically1
· Vito Volterra · 1926 · 2059 citations · Cited by this paper
APLP2 as a molecular link between immune regulation and bone metabolism in hepatocellular carcinoma: evidence from scRNA-seq and functional validation
· 2026 · Related
The first 30 years of p53: growing ever more complex
· Arnold J. Levine · 2009 · 2001 citations · Cited by this paper
Sphingolipid metabolic subtyping defines SPHK1 as an oncogene and characterizes immunosuppressive TME features in gastric cancer
· 2026 · Related
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
· Noopur S Raje · 2019 · 1781 citations · Cited by this paper
TMEM33 regulates the proliferation and migration of lung adenocarcinoma by promoting the PI3K/AKT/mTOR signaling pathway
· 2026 · Related
Mutual Interference Between Parasites or Predators and its Effect on Searching Efficiency
· John Rex Beddington · 1975 · 1734 citations · Cited by this paper
Integrative analysis of SLFN11-related DEGs reveals novel biomarkers for cisplatin sensitivity and immune modulation in colorectal cancer
· 2026 · Related
Coupling in predator-prey dynamics: Ratio-Dependence
· Roger Arditi · 1989 · 1517 citations · Cited by this paper
Immunotherapy resistance in colorectal cancer: therapeutic strategies and biomarker-guided approaches
· 2026 · Related
Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood
· Andreas Raue · 2009 · 1513 citations · Cited by this paper
The Wnt signaling networks in higher-grade meningiomas: from molecular pathogenesis to therapeutic innovation
· 2026 · Related
A Model for Tropic Interaction
· Donald Lee Deangelis · 1975 · 1339 citations · Cited by this paper
Fibronectin 1 mediates pressure-induced aggressive phenotypes in colorectal cancer cells and cancer stem cells
· 2026 · Related
Clinical implications of T cell exhaustion for cancer immunotherapy
· Andrew T. Chow · 2022 · 1044 citations · Cited by this paper
Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells
· Cameron John Turtle · 2016 · 1025 citations · Cited by this paper
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome
· Frank G. Rücker · 2011 · 696 citations · Cited by this paper
CAR immune cells: design principles, resistance and the next generation
· Louai Labanieh · 2023 · 670 citations · Cited by this paper
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
· Elsa Bernard · 2020 · 660 citations · Cited by this paper
On Identifiability of Nonlinear ODE Models and Applications in Viral Dynamics
· Hongyu Miao · 2011 · 638 citations · Cited by this paper
A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies
· Steffen Boettcher · 2019 · 449 citations · Cited by this paper
Understanding and interpreting confidence and credible intervals around effect estimates
· Luiz Hespanhol · 2018 · 408 citations · Cited by this paper
Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML
· Sascha Haubner · 2018 · 341 citations · Cited by this paper
A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia
· Gunilla Enblad · 2018 · 272 citations · Cited by this paper
Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia
· Eric Jay Feldman · 2005 · 251 citations · Cited by this paper
A framework for parameter estimation and model selection from experimental data in systems biology using approximate Bayesian computation
· Juliane Liepe · 2014 · 248 citations · Cited by this paper
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia
· Claire Roddie · 2024 · 239 citations · Cited by this paper
CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions
· Sherly Mardiana · 2020 · 237 citations · Cited by this paper
CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
· Jinghua Wang · 2018 · 205 citations · Cited by this paper
Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia
· Francesco Paolo Tambaro · 2021 · 195 citations · Cited by this paper
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype
· David Andrew Sallman · 2020 · 194 citations · Cited by this paper
Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia
· Anne Mary Dickinson · 2017 · 178 citations · Cited by this paper
Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells
· Renier Myburgh · 2020 · 98 citations · Cited by this paper
Source: OpenAlex (CC0)